Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease
Introduction: Cardiovascular disease (CVD) frequently co-exists with chronic kidney disease
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …
Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease.
N Katsiki, DP Mikhailidis, M Banach - Expert Opinion on …, 2019 - europepmc.org
Introduction: Cardiovascular disease (CVD) frequently co-exists with chronic kidney disease
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …
Lipid-lowering agents for concurrent cardiovascular and chronic kidney disease
N Katsiki, DP Mikhailidis… - Expert opinion on …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction: Cardiovascular disease (CVD) frequently co-exists with chronic kidney disease
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …
(CKD). Patients with concomitant CVD and CKD are at very high risk of CVD events. Areas …